The ADC Specialty Company

Our mission is to provide our clients impeccable service, technologies and superior quality for the discovery and development of new antibody drug conjugates. Creating the best solutions for cancer and other unmet medical needs is our highest priority for patients worldwide.

Levana Biopharma has built a one-stop-shop for ADCs from inception to clinic and beyond. Over the past 9 years we have developed a full suite of reagents, tools and capabilities to enable our clients and partners with the opportunity to produce best in class antibody drug conjugates.

Levena Biopharma’s product line encompasses a large portfolio of validated toxins and proven linkers. We also offer a variety of proprietary linkers and toxins conveniently available in test kits.  In combination with our proof-of-concept (POC) ADC conjugation services, our expert team of scientists can quickly evaluate your ADCs with detailed data, analysis and recommendations. We also provide cost-effective services for ADC optimization, process development, analytical testing and cGMP manufacturing.

Earlier this year we opened a new production facility in Suzhou, China. This is a 46,000 SF research and manufacturing site with synthesis,  ADC conjugation and biology capabilities. We are able to work with high potency APIs (HPAIs)  up to and including  SafeBridge category 4 . Our synthesis and conjugation suites cGMP areas are Class 10,000 (C) and Class 100 (D) in accordance with FDA’s Guidance for Aseptic Processing (2004). We have executed more than 400 projects for our customers and partners. We are committed to providing optimal solutions from first principles through commercial production.

cGMP ADC conjugation services

• Process Research and Development
• Analytical Methods and Stability Testing
• Bioactive linkers and toxins R&D
• ADC screening tools Test kits and reagents
• ADC optimization
• Fully functional CRO/CMO for your ADC